MYGN
Myriad Genetics Inc.
$3.87
+$0.05(+1.18%)
43
Overall
60
Value
27
Tech
44
Quality
Market Cap
$335.29M
Volume
768.50K
52W Range
$3.53 - $8.59
Target Price
$6.38
Order:
Income Statement
| Metric | Trend | Chart | 2016 Jun | 2017 Jun | 2018 Jun | 2019 Jun | 2020 Jun | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $753.8M | $769.9M | $743.7M | $851.1M | $638.6M | $690.6M | $678.4M | $753.2M | $837.6M | $824.5M | ||
| Total Revenue | $740.5M | $769.9M | $743.7M | $851.1M | $638.6M | $690.6M | $678.4M | $753.2M | $837.6M | $824.5M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-132.8M | $-145.2M | $-148.7M | $168.2M | $186.1M | $197.6M | -- | $236.2M | $252.2M | $247.9M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $596.5M | $598.7M | $566.5M | $682.9M | $452.5M | $504.9M | $678.4M | $517.0M | $585.4M | $576.6M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $429.7M | $550.8M | $505.8M | $641.4M | $584.5M | $619.7M | $600.1M | $774.4M | $708.9M | $963.8M | ||
| Research & Development | $70.6M | $74.4M | $70.8M | $85.9M | $77.2M | $81.9M | $85.4M | $88.7M | $113.4M | $106.8M | ||
| Research Expense | $70.6M | $74.4M | $70.8M | $85.9M | $77.2M | $81.9M | $85.4M | $88.7M | $113.4M | $106.8M | ||
| Selling, General & Administrative | $359.1M | $476.4M | $435.0M | $555.5M | $507.3M | $537.8M | $514.7M | $572.9M | $560.0M | $537.6M | ||
| Selling & Marketing Expenses | $359.1M | $476.4M | $435.0M | -- | -- | -- | -- | $289.2M | $284.1M | $280.8M | ||
| General & Administrative Expenses | $-14.3M | $-15.2M | $-15.5M | $555.5M | $507.3M | $537.8M | $514.7M | $283.7M | $275.9M | $256.8M | ||
| Salaries & Wages | $-31.6M | $-29.9M | $-27.1M | $33.5M | $25.2M | $36.3M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-26.7M | $-48.3M | $-54.4M | $73.0M | $11.0M | $12.1M | $11.6M | $19.1M | $19.5M | -- | ||
| Depreciation & Amortization | $-26.7M | $-48.3M | $-54.4M | $73.0M | $11.0M | $12.1M | -- | -- | -- | -- | ||
| Amortization | $-12.6M | $-33.3M | $-37.3M | $684.7M | $-7.3M | $404.1M | $379.7M | $287.4M | $286.3M | -- | ||
| Other Operating Expenses | $-600.0K | $-700.0K | $-600.0K | $-2.2M | $-1.6M | $-1.4M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $166.8M | $47.9M | $60.7M | $7.6M | $-231.7M | $-190.5M | $-140.6M | $-257.4M | $-123.5M | $-387.2M | ||
| EBITDA | $195.9M | $89.6M | $174.7M | $73.4M | $-140.5M | $12.3M | $-73.0M | $-186.1M | $-50.0M | $-323.2M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $300.0K | $6.0M | $3.2M | $12.0M | $10.8M | $6.6M | $3.2M | $2.9M | $2.8M | $10.5M | ||
| Intinc | $900.0K | $1.2M | $1.8M | $3.2M | $3.0M | $700.0K | $2.6M | $2.5M | $1.7M | $1.8M | ||
| Net Non-Operating Interest Income/Expense | $600.0K | $-4.8M | $-1.4M | $-8.8M | $-7.8M | $-5.9M | $-600.0K | $-400.0K | $-1.1M | $-8.7M | ||
| Other Income/Expense | $-1.5M | $2.2M | $-60.8M | $-100.0K | $-16.2M | $-139.3M | $-16.3M | $4.4M | $-1.1M | $-800.0K | ||
| Other Special Charges | $1.5M | $-3.0M | $-400.0K | $1.2M | $16.2M | $139.3M | $600.0K | $-4.4M | $1.1M | $800.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-102.2M | $-41.2M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | $102.2M | $41.2M | -- | -- | $-99.7M | $-63.8M | $-16.9M | $-112.8M | $-56.8M | $-319.4M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | $99.7M | $1.8M | $16.9M | -- | $56.8M | $319.4M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $169.2M | $41.3M | $120.3M | $400.0K | $-212.5M | $-50.5M | $-137.4M | $-259.3M | $-120.7M | $-384.6M | ||
| Pre-Tax Income | $168.9M | $40.9M | $120.1M | -- | $-223.3M | $-57.1M | $-140.6M | $-262.2M | $-123.5M | $-395.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $43.6M | $20.6M | $-13.0M | $-4.4M | $-23.7M | $-29.9M | $-28.6M | $1.1M | $3.8M | $-29.2M | ||
| NET INCOME | ||||||||||||
| Net Income | $125.3M | $20.5M | $133.3M | $4.6M | $-199.5M | $-27.2M | $-112.0M | $-263.3M | $-127.3M | $-365.9M | ||
| Net Income (Continuing Operations) | $125.3M | $20.5M | $133.3M | $4.6M | $-199.5M | $-27.2M | $-112.0M | $-263.3M | $-127.3M | $-365.9M | ||
| Net Income (Discontinued Operations) | $125.3M | $20.5M | $133.3M | $4.6M | $-199.5M | $-27.2M | $-112.0M | $-263.3M | $-127.3M | $-365.9M | ||
| Net Income (Common Stockholders) | $125.3M | $20.5M | $133.3M | $4.6M | $-199.5M | $-27.2M | $-112.0M | $-263.3M | $-127.3M | $-365.9M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-104.9M | ||
| TOTALS | ||||||||||||
| Total Expenses | $296.9M | $405.6M | $357.1M | $809.6M | $742.0M | $805.4M | $600.1M | $1.0B | $961.1M | $1.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $70.0M | $68.3M | $69.4M | $73.5M | $74.3M | $78.0M | $80.6M | $82.8M | $90.6M | $92.6M | ||
| Average Shares Outstanding (Diluted) | $73.4M | $68.8M | $72.0M | $76.0M | $74.3M | $78.0M | $80.6M | $82.8M | $90.6M | $92.6M | ||
| Shares Outstanding | $69.1M | $68.4M | $70.9M | $73.9M | $74.7M | $80.0M | $81.2M | $89.9M | $182.6M | $93.5M | ||
| Basic EPS | $1.79 | $0.32 | $1.89 | $0.06 | $-2.69 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.95 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $0.06 | $-2.69 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.95 | ||
| Diluted EPS | $1.71 | $0.32 | $1.82 | $0.06 | $-2.69 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.95 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $0.06 | $-2.69 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.95 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of Business | -- | -- | -- | -- | $1.0M | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | $1.0M | $162.0M | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | $-5.6M | $-3.0M | $-11.6M | $-9.5M | $-4.4M | -- | -- | -- | -- | ||
| Minority Interests | -- | $200.0K | $200.0K | $200.0K | $100.0K | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | $62.0M | -- | $112.8M | -- | -- | ||
| Other Gand A | $-14.3M | $-15.2M | $-15.5M | $555.5M | $507.3M | $537.8M | $514.7M | $283.7M | $275.9M | $256.8M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | $17.7M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-14.3M | $-15.2M | $-15.5M | $19.7M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $359.1M | $476.4M | $435.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-102.2M | $-41.2M | -- | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $3.87 | +1.2% | 768.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |